The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(2-((Ethyl(4-fluorophenyl)amino)methyl)-7-methyl-4-oxopyrazolo[1,5-a]pyrazin-5(4H)-yl)propanenitrile ID: ALA5194021
Chembl Id: CHEMBL5194021
PubChem CID: 168289223
Max Phase: Preclinical
Molecular Formula: C19H20FN5O
Molecular Weight: 353.40
Associated Items:
Names and Identifiers Canonical SMILES: CCN(Cc1cc2c(=O)n(CCC#N)cc(C)n2n1)c1ccc(F)cc1
Standard InChI: InChI=1S/C19H20FN5O/c1-3-23(17-7-5-15(20)6-8-17)13-16-11-18-19(26)24(10-4-9-21)12-14(2)25(18)22-16/h5-8,11-12H,3-4,10,13H2,1-2H3
Standard InChI Key: MMAHJSVBFSLTPC-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.40Molecular Weight (Monoisotopic): 353.1652AlogP: 2.88#Rotatable Bonds: 6Polar Surface Area: 66.33Molecular Species: NEUTRALHBA: 6HBD: 0#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 1.08CX LogP: 2.19CX LogD: 2.19Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.68Np Likeness Score: -1.99
References 1. Sakurai F, Yukawa T, Kina A, Murakami M, Takami K, Morimoto S, Seto M, Kamata M, Yamashita T, Nakashima K, Narita N, Bettini E, Ugolini A, Corsi M, Hasui T.. (2022) Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity., 56 [PMID:35051811 ] [10.1016/j.bmc.2021.116576 ]